The cost-effectiveness of screening for colorectal cancer.
about
The usefulness of routine histopathology of bilateral nasal polyps - a systematic review, meta-analysis, and cost evaluationCancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screeningA simulation model of colorectal cancer surveillance and recurrence.Effect of payment incentives on cancer screening in Ontario primary care.Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010.Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review.Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians.Recommendations on screening for colorectal cancer in primary care.Computer disease simulation models: integrating evidence for health policy.Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for CanadaCanadian guidelines for colorectal cancer screening.Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, CanadaHarms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screeningUse of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study.Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIVPrimary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.Review of economic evidence in the prevention and early detection of colorectal cancer.Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening ProgramColorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.Performance of a quantitative fecal immunochemical test in a colorectal cancer screening pilot program: a prospective cohort study.Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.Colorectal cancer surveillance: what's new and what's nextDoes acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature.Colonoscopy: the current king of the hill in the USA.A framework for evaluating the cost-effectiveness of patient decision aids: A case study using colorectal cancer screening.Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.Mathematical models and cost-effective screening strategies for colorectal cancer.Fighting colorectal cancer with information technology.Fecal occult blood testing while waiting for screening colonoscopy in average-risk individuals: durable option or short-term solution?Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening.Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta's Tomorrow Project participants stratified by risk.Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history.Characteristics of Patients with Colonic Polyps Requiring Segmental Resection.Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.
P2860
Q26780136-AB60B5A6-F0B1-4165-B92E-0A4922DCCB3DQ26864419-822B8EEE-A393-44BF-9104-6E3764B94513Q33613715-4CD0BAC0-4224-4ADE-A393-DEE16C0D4F33Q33895457-D4331E7E-3E36-4100-BA9E-3A6EE4AED7EAQ34417133-C6D3D9E0-4662-401E-AB0B-7FFC8F5410A4Q34420202-0CF7124E-D996-45E0-BD9D-650B3F0BB835Q34509357-BBF091B3-8FFF-403E-AEC0-F05A62FEEEB9Q34515159-3DD54867-4FE1-47C9-9CA8-85E45255F462Q35074556-20587047-CAF0-4D34-9168-5DC722DAF38AQ35445134-44294875-2100-474B-8213-1B7785F0263EQ35452917-8B667A54-E905-4C9A-9B00-33F3C1348A46Q35544801-65AF260D-8428-4C0F-A5AE-13FA142F1FA3Q35809264-AFDA52AB-9E7C-4C6A-92FE-7083921A4DDAQ35835091-DA3BB5C2-546A-47E3-840D-9D6F3523683CQ36033510-E4C4EEA9-5FA7-4D0C-98BF-D945AB29BB88Q36272784-A855061F-D5D9-4637-ABB6-19524813C9BAQ36309075-4FC4AB46-7069-4626-AF58-ABDD635DE4F6Q36405811-19811E6A-ABD8-4AB1-B577-48AF83DFC635Q36652063-23A17B96-E74D-48A6-9633-FE9EAEE26FB0Q36759309-541E0EFB-3562-4631-8827-A1F1C4D455DEQ37356637-CF461609-8065-4EA3-AB25-3611DFC9BAC3Q37503972-2138FE0E-ED54-4F27-B6CD-8B1FF69B9FBAQ37507961-CE4AED7D-6D46-4218-84D1-2499B2BC6A3BQ37521021-ED7F56B8-7498-48D8-8891-CB6846EA627EQ37571510-DD91B361-0242-4BE2-960D-12F60E8D530EQ37602712-2319B167-33C8-4FC5-8BF0-F842E9A23E4BQ38091719-C75C5E94-4794-40F5-8793-A0950A2B5473Q38095383-71D86B4B-5893-40F8-BE7C-CAE337BCD916Q38289754-0FF0DCE0-A603-4C2A-9DDD-8D4A423325A3Q38483811-1C31C54F-8AAB-43EE-A6C7-0B630726AA7BQ38754674-49845E3C-FF18-4F67-B482-8C8A12122D27Q42430390-519F6214-E032-4A61-8529-06821D8E6DD2Q42757189-75B01D79-37D7-44A6-B686-9513FDF5B98CQ42757381-5BD85516-ED78-4EB8-83EE-C5B5E69F36A9Q43493798-89B538A9-7D8A-445E-930E-220942EC346AQ47991700-1FDB8FE6-70F5-4AF0-9148-1EA951099DD6Q48164413-C118809B-5068-4289-A4B2-1D3860C9944DQ50944307-01873397-56CC-46A0-BD84-E764D3FE6886Q52578953-53945348-D8A2-434A-B5C0-5F2B8FC40283Q53172550-C5A10CC5-5F17-4644-B179-489FC2E01224
P2860
The cost-effectiveness of screening for colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
The cost-effectiveness of screening for colorectal cancer.
@ast
The cost-effectiveness of screening for colorectal cancer.
@en
The cost-effectiveness of screening for colorectal cancer.
@nl
type
label
The cost-effectiveness of screening for colorectal cancer.
@ast
The cost-effectiveness of screening for colorectal cancer.
@en
The cost-effectiveness of screening for colorectal cancer.
@nl
prefLabel
The cost-effectiveness of screening for colorectal cancer.
@ast
The cost-effectiveness of screening for colorectal cancer.
@en
The cost-effectiveness of screening for colorectal cancer.
@nl
P2093
P2860
P356
P1476
The cost-effectiveness of screening for colorectal cancer.
@en
P2093
Adrian R Levy
Denise Zou
Jennifer C Sambrook
Jennifer J Telford
Robert A Enns
P2860
P304
P356
10.1503/CMAJ.090845
P407
P577
2010-07-12T00:00:00Z